Subscribe
georgeclerk-1
georgeclerk / iStockphoto.com
27 September 2017Big Pharma

UK health committee to investigate pharma regulation after Brexit

The UK’s House of Commons has launched an investigation into post-Brexit regulatory agreements needed to guarantee the safe and effective supply of medicines and medical devices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
UK life sciences receives £160m government funding
30 August 2017   The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry.
Big Pharma
House of Lords hears evidence on life sciences and Brexit
17 October 2017   The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Big Pharma
UK life sciences receives £160m government funding
30 August 2017   The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry.
Big Pharma
House of Lords hears evidence on life sciences and Brexit
17 October 2017   The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry.

More on this story

Big Pharma
UK life sciences receives £160m government funding
30 August 2017   The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry.
Big Pharma
House of Lords hears evidence on life sciences and Brexit
17 October 2017   The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent